Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Immunization”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Large-scale testing (Phase 3)Looking for participantsNCT06955728
What this trial is testing

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Who this might be right for
RSV InfectionsRSV ImmunisationPreterm Labour
University of Witwatersrand, South Africa 13,000
Early research (Phase 1)Active Not RecruitingNCT06564194
What this trial is testing

Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)Infectious Disease
Immorna Biotherapeutics, Inc. 75
Not applicableStudy completedNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,792
Not applicableStudy completedNCT06185647
What this trial is testing

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Hôpital Armand Trousseau 4,924
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Study completedNCT06194318
What this trial is testing

First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Vaccination
Clover Biopharmaceuticals AUS Pty 160
Not applicableActive Not RecruitingNCT06647654
What this trial is testing

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

Who this might be right for
Respiratory Syncytial VirusRespiratory Tract Diseases
Pfizer 1
Not applicableLooking for participantsNCT06172660
What this trial is testing

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Who this might be right for
RSV Infection
Yale University 3,750
Large-scale testing (Phase 3)Ended earlyNCT06705140
What this trial is testing

A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunisation
Sanofi Pasteur, a Sanofi Company 947
Post-approval studies (Phase 4)Study completedNCT06551506
What this trial is testing

The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 181
Large-scale testing (Phase 3)Ended earlyNCT06397768
What this trial is testing

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunization
Sanofi Pasteur, a Sanofi Company 2,226
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Not applicableActive Not RecruitingNCT07122661
What this trial is testing

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Syncytial VirusLower Respiratory Tract Disease+2 more
Pfizer 1
Not applicableNot Yet RecruitingNCT07279298
What this trial is testing

Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV

Who this might be right for
Respiratory Syncytial Virus InfectionsSevere Acute Respiratory InfectionBronchiolitis, Viral+1 more
Bogotá District Health Secretariat 1,097
Not applicableStudy completedNCT02282982
What this trial is testing

Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 359
Large-scale testing (Phase 3)Study completedNCT02624947
What this trial is testing

Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Who this might be right for
Respiratory Syncytial Virus Infections
Novavax 4,636
Testing effectiveness (Phase 2)Study completedNCT04785612
What this trial is testing

Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Hvivo 70
Not applicableNot Yet RecruitingNCT07235397
What this trial is testing

Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 1
Load More Results